The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Accelerated Review Options (AROs)
-
Good Morning @agency and @manufacturer
The highly anticipated Accelerated Review Options (AROs) Planned Features Document is now available for your viewing pleasure.
Learn about the proposed features and how the roll out is set to start. Feel free to reach out with any questions by posting questions and comments in this section of the Forum.
We look forward to growing this new set of review options with you!
